NuMedii Receives $3.5M in a Series A Financing From Claremont Creek Ventures and Lightspeed Venture Partners
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
PALO ALTO, Calif.--(BUSINESS WIRE)--NuMedii, Inc. today announced that it has received $3.5M in a Series A funding led by Claremont Creek Ventures and Lightspeed Venture Partners, with participation by Life Science Angels and others. NuMedii raised this initial funding to further develop its proprietary technology and prepare its first three internal drug development programs for clinical testing.
Help employers find you! Check out all the jobs and post your resume.
PALO ALTO, Calif.--(BUSINESS WIRE)--NuMedii, Inc. today announced that it has received $3.5M in a Series A funding led by Claremont Creek Ventures and Lightspeed Venture Partners, with participation by Life Science Angels and others. NuMedii raised this initial funding to further develop its proprietary technology and prepare its first three internal drug development programs for clinical testing.
Help employers find you! Check out all the jobs and post your resume.